Pharmaceutics 2011, 3(2), 186-228; doi:10.3390/pharmaceutics3020186
Article

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

Kara M. George 1 , Marie-Céline Frantz 1 , Karla Bravo-Altamirano 1 , Courtney R. LaValle 2 , Manuj Tandon 2 , Stephanie Leimgruber 2 , Elizabeth R. Sharlow 2,3 , John S. Lazo 2,3 , Q. Jane Wang 2  and Peter Wipf 1,* email
1 Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA 2 Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260, USA 3 Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA
* Author to whom correspondence should be addressed.
Received: 17 February 2011; in revised form: 1 April 2011 / Accepted: 19 April 2011 / Published: 21 April 2011
(This article belongs to the Special Issue Drug Discovery Tools)
PDF Full-text Download PDF Full-Text [1040 KB, uploaded 21 April 2011 11:03 CEST]
Abstract: Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.
Keywords: protein kinase D; small molecule inhibitor; benzothienothiazepinone; pyrimidines; CID755673; thiazepinothiophenopyrimidinone

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

George, K.M.; Frantz, M.-C.; Bravo-Altamirano, K.; LaValle, C.R.; Tandon, M.; Leimgruber, S.; Sharlow, E.R.; Lazo, J.S.; Wang, Q.J.; Wipf, P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics 2011, 3, 186-228.

AMA Style

George KM, Frantz M-C, Bravo-Altamirano K, LaValle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics. 2011; 3(2):186-228.

Chicago/Turabian Style

George, Kara M.; Frantz, Marie-Céline; Bravo-Altamirano, Karla; LaValle, Courtney R.; Tandon, Manuj; Leimgruber, Stephanie; Sharlow, Elizabeth R.; Lazo, John S.; Wang, Q. Jane; Wipf, Peter. 2011. "Design, Synthesis, and Biological Evaluation of PKD Inhibitors." Pharmaceutics 3, no. 2: 186-228.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert